HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ines Batinic-Haberle Selected Research

AEOL 10150

9/2011Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
11/2007Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.
2/2007Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.
8/2004Mouse spinal cord compression injury is ameliorated by intrathecal cationic manganese(III) porphyrin catalytic antioxidant therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ines Batinic-Haberle Research Topics

Disease

43Neoplasms (Cancer)
11/2021 - 09/2002
7Hypoxia (Hypoxemia)
01/2019 - 01/2007
7Lung Injury
10/2010 - 09/2002
5Wounds and Injuries (Trauma)
01/2021 - 04/2011
5Brain Neoplasms (Brain Tumor)
01/2021 - 02/2011
5Glioma (Gliomas)
01/2021 - 02/2009
5Glioblastoma (Glioblastoma Multiforme)
02/2016 - 02/2009
4Carcinoma (Carcinomatosis)
11/2021 - 05/2006
4Breast Neoplasms (Breast Cancer)
11/2021 - 10/2009
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 11/2015
4Carcinogenesis
01/2019 - 02/2005
4Radiation Injuries (Radiation Sickness)
03/2018 - 01/2007
4Ischemia
03/2013 - 05/2007
3Inflammation (Inflammations)
01/2021 - 11/2007
3Fibrosis (Cirrhosis)
03/2018 - 11/2007
3Lymphoma (Lymphomas)
06/2015 - 01/2012
3Inflammatory Breast Neoplasms
03/2014 - 02/2012
2Neoplasm Metastasis (Metastasis)
11/2021 - 01/2019
2Hypotension (Low Blood Pressure)
01/2020 - 05/2013
2Pneumonia (Pneumonitis)
03/2018 - 01/2018
2Adenocarcinoma
01/2014 - 11/2007
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2013 - 02/2002
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2013 - 08/2009
2Mitochondrial Diseases (Mitochondrial Disease)
07/2013 - 05/2012
2Reperfusion Injury
03/2013 - 12/2011
2Necrosis
03/2013 - 03/2008
2Prostatic Neoplasms (Prostate Cancer)
11/2012 - 11/2011
2Hyperthermia
11/2010 - 10/2009
2Body Weight (Weight, Body)
04/2010 - 03/2008
2Colonic Neoplasms (Colon Cancer)
01/2007 - 05/2006
2Spinal Cord Compression
08/2004 - 05/2004
1Anus Neoplasms (Anal Cancer)
01/2021
1Atopic Dermatitis (Atopic Eczema)
01/2021
1Leukocytosis (Pleocytosis)
01/2020
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Stroke (Strokes)
01/2020
1Ischemic Stroke
01/2020
1Acute Pain
01/2020
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Anemia
01/2020
1Kidney Neoplasms (Kidney Cancer)
10/2019
1Second Primary Neoplasms (Neoplasms, Second)
01/2019
1Pathologic Constriction (Stenosis)
10/2018
1Sclerosis
10/2018

Drug/Important Bio-Agent (IBA)

35PorphyrinsIBA
08/2021 - 10/2005
16Superoxide DismutaseIBA
11/2021 - 02/2002
16ManganeseIBA
01/2021 - 08/2004
15AntioxidantsIBA
01/2019 - 02/2002
13Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 02/2002
11Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2009
7Pharmaceutical PreparationsIBA
01/2020 - 10/2005
5Mn(III) meso- tetrakis(N- n- butoxyethylpyridinium- 2- yl)porphyrinIBA
02/2016 - 05/2014
4manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrinIBA
01/2021 - 03/2008
4Mn(III) ortho- tetrakis(N- hexylpyridinium- 2- yl)porphyrinIBA
10/2019 - 03/2008
4AEOL 10150IBA
09/2011 - 08/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2010 - 01/2007
4CytokinesIBA
01/2007 - 02/2002
3EnzymesIBA
01/2019 - 11/2007
3MetalsIBA
12/2018 - 02/2011
3Glutathione (Reduced Glutathione)IBA
11/2018 - 03/2014
3Oxygen (Dioxygen)IBA
01/2017 - 03/2008
3Peroxynitrous Acid (Peroxynitrite)IBA
07/2013 - 10/2009
3MetalloporphyrinsIBA
11/2012 - 02/2002
3NADPH Oxidases (NAD(P)H oxidase)IBA
05/2011 - 10/2009
3NADP (NADPH)IBA
05/2011 - 02/2009
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
02/2011 - 11/2007
2hydroxide ionIBA
01/2020 - 05/2013
2manganese(III) porphyrinIBA
01/2019 - 08/2004
2Glutathione PeroxidaseIBA
11/2018 - 01/2007
2Phosphotransferases (Kinase)IBA
11/2017 - 11/2013
2Radiation-Sensitizing AgentsIBA
11/2017 - 11/2015
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 01/2016
2CathepsinsIBA
01/2017 - 11/2015
2LigandsIBA
02/2016 - 05/2006
2Sulfhydryl Compounds (Thiols)IBA
02/2016 - 05/2014
2Oxidoreductases (Dehydrogenase)IBA
05/2011 - 02/2009
2DNA (Deoxyribonucleic Acid)IBA
05/2011 - 10/2009
2NitrogenIBA
04/2010 - 03/2008
2Transforming Growth Factor beta (TGF-beta)IBA
04/2010 - 01/2007
2Dichlorodiphenyldichloroethane (DDD)IBA
10/2009 - 08/2004
1salicylhydroxamic acid (SHAM)IBA
11/2021
1Hyaluronic Acid (Hyaluronan)IBA
08/2021
1IonsIBA
08/2021
1Biological ProductsIBA
08/2021
1LipopolysaccharidesIBA
01/2021
1PhosphatidylserinesIBA
01/2020
1GasesIBA
01/2020
1Anti-Arrhythmia AgentsIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Mitogen-Activated Protein Kinase PhosphatasesIBA
12/2018
1Mitogen-Activated Protein KinasesIBA
12/2018
1Glutathione Disulfide (GSSG)FDA LinkGeneric
11/2018
1Protein SIBA
11/2018
1CollagenIBA
10/2018
1Free RadicalsIBA
03/2018

Therapy/Procedure

17Therapeutics
01/2021 - 08/2004
13Radiotherapy
11/2021 - 09/2002
7Drug Therapy (Chemotherapy)
01/2019 - 10/2009
2Warm Ischemia
03/2013 - 12/2011
1Negative-Pressure Wound Therapy
01/2019